FY2021 capital investment primarily in the prescription pharmaceuticals wholesale business
A theme concerning capital investment totaling ¥25.265 billion in FY2021, primarily in the wholesale business for prescription pharmaceuticals and related products. It covers investment results for a specific fiscal year and the businesses targeted.
Companies1How many companies write about this.
Threads1One company can carry more than one thread here.